Explainer6 min read
GLP-1 supplements vs GLP-1 drugs: what GLP-1 boosters actually do
Berberine, fiber, and probiotics sold as GLP-1 boosters are not GLP-1 drugs. Here is the human evidence for each ingredient, graded, and how it compares with semaglutide and tirzepatide.
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The short answer: GLP-1 supplements are not GLP-1 drugs. Products sold as "GLP-1 boosters" contain ingredients such as berberine, fiber, or probiotics, and none of them is a GLP-1 receptor agonist. As dietary supplements they are not approved by FDA before sale and may not claim to treat obesity or diabetes. [1] A few of these ingredients have randomized trials showing small effects on weight, on the order of 1 to 4 kg. The approved drugs, semaglutide and tirzepatide, produce average losses several times larger.
Below, each common booster ingredient is graded by the human evidence behind it. We do not name supplement brands.
What is a GLP-1 supplement?
GLP-1 is a hormone released by the gut after a meal. It prompts insulin release, slows stomach emptying, and helps regulate appetite. Your own GLP-1 is broken down by the enzyme DPP-4 extremely quickly, much of it before it leaves the gut. [2] That is the core problem for any "booster": nudging your own GLP-1 up after a meal produces a brief signal.
The drugs work differently. Semaglutide and tirzepatide are engineered to resist breakdown, which is why they are dosed once weekly by injection, with semaglutide also available as a daily tablet. [3] [4] Tirzepatide also acts on a second receptor, GIP. [3] Supplements do not act on either receptor.
Do GLP-1 supplements work? The human evidence, ingredient by ingredient
For scale: in SURMOUNT-1, tirzepatide 15 mg produced a mean weight change of minus 20.9% at 72 weeks versus minus 3.1% on placebo. [5] In STEP 1, semaglutide 2.4 mg produced minus 14.9% at 68 weeks versus minus 2.4%. [6] Keep those numbers in mind as you read the supplement results, which are reported in kilograms, not percent.
Berberine (graded: human randomized trials, modest effect)
Berberine is a plant compound sometimes marketed as "nature's Ozempic." In a cell study, it triggered GLP-1 release from human intestinal cells through bitter taste receptors. [7] In people, a 2020 meta-analysis of 12 randomized trials found that it lowered body weight by an average of 2.07 kg and waist circumference by about 1 cm. [8] In type 2 diabetes, a 2022 meta-analysis of 37 trials found an average HbA1c reduction of 0.63 percentage points. [9] That analysis drew heavily on trials indexed in Chinese-language databases, which is worth knowing when judging how well the results generalize. [9] Berberine is a real signal, but it is not a GLP-1 drug and it is not in the same range.
Fiber: psyllium, glucomannan, and other viscous fibers (graded: human randomized trials, small effect)
Viscous fibers form a gel in the gut, which can slow digestion. Across 15 randomized trials in people on calorie-restricted diets, adding viscous fiber produced an extra 0.81 kg of weight loss on average. [10] A 2023 network meta-analysis of 111 trials estimated a larger effect for psyllium, about 3.70 kg, with moderate certainty, and about 1.36 kg for glucomannan, with low certainty. [11] Fiber is also easy to get from food.
Probiotics and Akkermansia (graded: human randomized trials, very small effect)
A meta-analysis of randomized trials in adults with overweight or obesity found that probiotics reduced body weight by an average of 0.60 kg, an effect the authors described as small; the effect on fat mass was not significant. [12] Akkermansia muciniphila, a gut bacterium sold as a GLP-1 probiotic, has one small proof-of-concept trial: among 32 people who completed it, pasteurized Akkermansia improved insulin sensitivity, and the 2.27 kg drop in body weight versus placebo was not statistically significant. [13]
Green tea extract and chromium (graded: human randomized trials, little or no effect)
A Cochrane review found that green tea preparations produced a small, statistically non-significant weight loss in adults with overweight or obesity. [14] Another Cochrane review found an effect of about 1.1 kg for chromium picolinate, of debatable clinical relevance, from low-quality evidence. [15]
The bigger picture on weight loss supplements
A systematic review of 315 randomized trials of weight loss supplements and alternative therapies found that only 52 were at low risk of bias with enough data to judge, and only 16 of those showed a significant difference in weight, ranging from 0.3 to 4.93 kg. [16] The authors concluded that the high-quality evidence base is limited. The Federal Trade Commission expects health claims for such products to rest on competent and reliable scientific evidence, generally randomized human trials, and says consumer testimonials never suffice. [17] A label that says "GLP-1" rarely comes with a trial of that product.
GLP-1 supplements vs GLP-1 drugs: side by side
- What they are. Drugs: GLP-1 receptor agonists, FDA approved with labeled doses and warnings. [3] [4] Supplements: food-derived ingredients, not reviewed by FDA before sale. [1]
- Typical effect in trials. Drugs: mean losses of about 15% to 21% of body weight. [5] [6] Supplements: about 1 to 4 kg for the best-supported ingredients. [8] [11]
- Access. Drugs need a prescription and cost more, though cash prices have fallen: see semaglutide cost and tirzepatide cost. Supplements are sold over the counter.
- Risks. Drugs carry labeled risks, including gastrointestinal effects and a boxed warning about thyroid C-cell tumors seen in rodents. [3] Supplements carry quality risks, covered next.
Our semaglutide vs tirzepatide comparison goes deeper on the two drugs, and the obesity and type 2 diabetes condition pages grade every option we track.
Safety: hidden drugs and fake GLP-1 products
The weight loss aisle has a long record of contamination. FDA has repeatedly found products marketed for weight loss, including supplements and teas, that contain hidden drug ingredients, and warns they can cause serious harm. [18] Separately, FDA has warned about unapproved GLP-1 products sold online, including items labeled for research use, which may contain the wrong ingredient, too much, too little, or none. [19] A product that claims to contain actual semaglutide or tirzepatide without a prescription is in that group, not the supplement group.
If you take diabetes medicine, talk to your clinician before adding berberine or any other product marketed to lower blood sugar.
What to do instead
If you want the effect of a GLP-1 drug, the lawful route is a prescription from a licensed clinician; our guide on how to get peptides prescribed and the GLP-1 hub cover it, and our state legal guides cover telehealth rules. If you are looking at patch versions of these products, see do GLP-1 patches work. And if you want a supplement for modest help alongside diet changes, fiber has the most consistent, if small, human evidence.
Decisions about starting, stopping, or combining any treatment belong with a licensed clinician who knows your history.
Pages referenced in this article
- PeptideSemaglutide
- PeptideTirzepatide
- ComparisonSemaglutide vs tirzepatide
- ConditionObesity and chronic weight management
- ConditionType 2 diabetes
- CostSemaglutide cost
- CostTirzepatide cost
- IndexState legal guides
Frequently asked questions
Do GLP-1 supplements work like Ozempic or Zepbound?
No. The drugs are GLP-1 receptor agonists engineered for once-weekly injection or daily tablets. Supplements sold as GLP-1 boosters contain food-derived ingredients, and the best-studied of them, berberine, lowered weight by about 2 kg on average in trials, compared with mean losses of about 15% to 21% of body weight in the main semaglutide and tirzepatide trials. [3] [4] [5] [6] [8]
Is berberine nature's Ozempic?
No. Berberine triggered GLP-1 release in a cell study, and oral berberine lowered weight by an average of 2.07 kg across 12 randomized trials. That is a modest effect from a different mechanism, not a GLP-1 drug. [7] [8]
Does fiber work as a GLP-1 booster?
Not in the way a GLP-1 drug works, but viscous fiber does help a little with weight: a meta-analysis of 15 trials found an extra 0.81 kg of weight loss when it was added to a calorie-restricted diet. [10]
Are GLP-1 supplements FDA approved?
No. FDA does not approve dietary supplements before they are sold, and a supplement may not claim to treat or prevent a disease such as obesity or diabetes. [1]
Can a GLP-1 supplement be dangerous?
It can be. FDA has repeatedly found products marketed for weight loss with hidden drug ingredients, and has warned about unapproved GLP-1 products sold online that may contain the wrong ingredient or dose. [18] [19]
Sources
Numbered citations in the article point to these primary sources. PubMed entries link to the indexed abstract. Evidence grades follow our methodology.
- [1]FDA: Questions and answers on dietary supplements (definition, premarket approval, and disease claims)FDA
- [2]Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007PubMed 17928588, 2007
- [3]FDA prescribing information for Zepbound (tirzepatide) injection, via DailyMedFDA
- [4]FDA prescribing information for Wegovy (semaglutide) injection and tablets, via DailyMedFDA
- [5]Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med 2022 (SURMOUNT-1)PubMed 35658024, 2022
- [6]Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021 (STEP 1)PubMed 33567185, 2021
- [7]Yu Y et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol 2015PubMed 26206195, 2015
- [8]Asbaghi O et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN 2020PubMed 32690176, 2020
- [9]Xie W et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol 2022PubMed 36467075, 2022
- [10]Jovanovski E et al. Effect of viscous fiber supplementation on obesity indicators in individuals consuming calorie-restricted diets: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr 2021PubMed 32198674, 2021